×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions by Thompson Peter A.

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
EWTXEdgewise Therapeutics, Inc.Thompson Peter A.DirectorJan 23, 2024Buy$11.00454,5454,999,99514,436,497Jan 25, 2024, 04:32 PM
ALPNALPINE IMMUNE SCIENCES, INC.Thompson Peter A.DirectorJan 11, 2024Option Exercise$12.74145,2511,850,4982,416,181Jan 16, 2024, 04:36 PM
ALPNALPINE IMMUNE SCIENCES, INC.Thompson Peter A.DirectorDec 28, 2023Sale$18.351,364,84925,049,0333,466,613Dec 29, 2023, 04:20 PM
ALPNALPINE IMMUNE SCIENCES, INC.Thompson Peter A.DirectorDec 27, 2023Sale$19.96181,4983,622,7003,493,485Dec 29, 2023, 04:20 PM
SPRYARS Pharmaceuticals, Inc.Thompson Peter A.DirectorAug 29, 2023Buy$6.20500,0003,100,0008,019,187Aug 31, 2023, 05:18 PM
EWTXEdgewise Therapeutics, Inc.Thompson Peter A.DirectorSep 16, 2022Buy$10.32484,4964,999,99913,981,952Sep 16, 2022, 04:34 PM
EWTXEdgewise Therapeutics, Inc.Thompson Peter A.DirectorMay 18, 2022Buy$7.21138,000994,98013,497,456May 20, 2022, 04:32 PM
JANXJanux Therapeutics, Inc.Thompson Peter A.DirectorDec 29, 2021Sale$20.3040,400820,1202,258,566Dec 30, 2021, 08:55 PM
JANXJanux Therapeutics, Inc.Thompson Peter A.DirectorDec 21, 2021Sale$19.00119,4002,268,6002,295,266Dec 23, 2021, 04:08 PM
JANXJanux Therapeutics, Inc.Thompson Peter A.DirectorDec 16, 2021Sale$19.07393,3007,500,2312,403,566Dec 17, 2021, 05:16 PM
CRVSCorvus Pharmaceuticals, Inc.Thompson Peter A.DirectorSep 20, 2021Sale$6.091,109,6446,757,7326,943,654Sep 22, 2021, 05:24 PM
ALPNALPINE IMMUNE SCIENCES, INC.Thompson Peter A.DirectorSep 17, 2021Buy$9.401,010,6379,499,9873,656,061Sep 21, 2021, 06:38 PM
JANXJanux Therapeutics, Inc.Thompson Peter A.DirectorJun 15, 2021Buy$17.00705,85311,999,5012,760,366Jun 16, 2021, 06:20 PM
EWTXEdgewise Therapeutics, Inc.Thompson Peter A.DirectorMar 30, 2021Buy$16.00359,3755,750,00013,359,456Mar 31, 2021, 07:11 PM
DBTXDecibel Therapeutics, Inc.Thompson Peter A.DirectorFeb 17, 2021Buy$18.001,666,66629,999,9883,843,206Feb 19, 2021, 06:50 PM
CRVSCorvus Pharmaceuticals, Inc.Thompson Peter A.DirectorFeb 17, 2021Buy$3.501,285,7144,499,9998,053,298Feb 19, 2021, 04:47 PM
ALPNALPINE IMMUNE SCIENCES, INC.Thompson Peter A.DirectorDec 28, 2020Sale$14.25600,0008,550,0003,070,955Dec 30, 2020, 04:38 PM
SBTXSilverback Therapeutics, Inc.Thompson Peter A.DirectorDec 08, 2020Buy$21.00952,37719,999,917952,377Dec 08, 2020, 08:43 PM
SBTXSilverback Therapeutics, Inc.Thompson Peter A.DirectorDec 08, 2020Buy$21.00238,1005,000,100507,423Dec 08, 2020, 08:43 PM
PMVPPMV Pharmaceuticals, Inc.Thompson Peter A.DirectorSep 25, 2020Buy$18.00950,00017,100,000475,000Sep 29, 2020, 04:38 PM
THORSynthorx, Inc.Thompson Peter A.DirectorJan 23, 2020Option Exercise$68.005,316,355361,512,1400Jan 24, 2020, 06:44 PM
CRVSCorvus Pharmaceuticals, Inc.Thompson Peter A.DirectorAug 06, 2019Buy$3.51142,656500,7236,767,584Aug 08, 2019, 05:00 PM
CRVSCorvus Pharmaceuticals, Inc.Thompson Peter A.DirectorJun 28, 2019Buy$3.72565,1782,102,4626,565,685Jul 01, 2019, 06:16 PM
CRVSCorvus Pharmaceuticals, Inc.Thompson Peter A.DirectorJul 01, 2019Buy$3.9159,243231,6406,624,928Jul 01, 2019, 06:16 PM
CRVSCorvus Pharmaceuticals, Inc.Thompson Peter A.DirectorJun 27, 2019Buy$3.3432,923109,9636,000,507Jul 01, 2019, 06:16 PM
PRVLPrevail Therapeutics Inc.Thompson Peter A.DirectorJun 24, 2019Buy$17.00882,35214,999,98413,822,463Jun 26, 2019, 04:56 PM
ALPNALPINE IMMUNE SCIENCES, INC.Thompson Peter A.DirectorJan 18, 2019Buy$5.37372,4391,999,9973,670,955Jan 23, 2019, 06:01 PM
THORSynthorx, Inc.Thompson Peter A.DirectorDec 11, 2018Buy$11.001,363,63614,999,9965,316,355Dec 13, 2018, 06:37 PM
ADAPAdaptimmune Therapeutics PLCThompson Peter A.DirectorJun 06, 2018Sale$13.491,60021,5844,901,310Jun 06, 2018, 06:16 PM
ADAPAdaptimmune Therapeutics PLCThompson Peter A.DirectorJun 04, 2018Sale$13.5717,100232,0474,902,910Jun 06, 2018, 06:16 PM
ADAPAdaptimmune Therapeutics PLCThompson Peter A.DirectorMay 30, 2018Sale$13.52121,0001,635,9204,970,010Jun 01, 2018, 05:27 PM
ADAPAdaptimmune Therapeutics PLCThompson Peter A.DirectorJun 01, 2018Sale$13.4950,000674,5004,920,010Jun 01, 2018, 05:27 PM
ADAPAdaptimmune Therapeutics PLCThompson Peter A.DirectorMay 14, 2018Sale$13.5010,300139,0505,091,010May 16, 2018, 05:26 PM
ADAPAdaptimmune Therapeutics PLCThompson Peter A.DirectorMar 27, 2018Sale$11.501,016,08411,684,9665,133,293Mar 29, 2018, 06:58 PM
ADAPAdaptimmune Therapeutics PLCThompson Peter A.DirectorMar 29, 2018Sale$11.5331,983368,7645,101,310Mar 29, 2018, 06:58 PM
CRVSCorvus Pharmaceuticals, Inc.Thompson Peter A.DirectorMar 12, 2018Buy$8.50588,2354,999,9985,967,584Mar 14, 2018, 02:05 PM
ADAPAdaptimmune Therapeutics PLCThompson Peter A.DirectorMar 27, 2017Buy$4.201,190,4764,999,9996,149,377Mar 28, 2017, 06:54 PM
CRVSCorvus Pharmaceuticals, Inc.Thompson Peter A.DirectorJun 23, 2016Buy$12.921001,2925,378,449Jun 27, 2016, 06:51 PM
CRVSCorvus Pharmaceuticals, Inc.Thompson Peter A.DirectorJun 24, 2016Buy$12.9990011,6915,379,349Jun 27, 2016, 06:51 PM
CRVSCorvus Pharmaceuticals, Inc.Thompson Peter A.DirectorJun 17, 2016Buy$12.4812,300153,5045,352,266Jun 21, 2016, 07:00 PM
CRVSCorvus Pharmaceuticals, Inc.Thompson Peter A.DirectorJun 21, 2016Buy$12.8726,083335,6885,378,349Jun 21, 2016, 07:00 PM
RBMRESPONSE BIOMEDICAL CORPThompson Peter A.DirectorJun 16, 2016Buy$0.56892,858500,0003,604,266Jun 20, 2016, 05:44 PM
CRVSCorvus Pharmaceuticals, Inc.Thompson Peter A.DirectorJun 14, 2016Buy$12.7110,000127,1005,329,966Jun 16, 2016, 06:05 PM
CRVSCorvus Pharmaceuticals, Inc.Thompson Peter A.DirectorJun 15, 2016Buy$11.945,00059,7005,334,966Jun 16, 2016, 06:05 PM
CRVSCorvus Pharmaceuticals, Inc.Thompson Peter A.DirectorJun 16, 2016Buy$12.045,00060,2005,339,966Jun 16, 2016, 06:05 PM
CRVSCorvus Pharmaceuticals, Inc.Thompson Peter A.DirectorJun 09, 2016Buy$12.9530,000388,5005,299,966Jun 13, 2016, 05:23 PM
CRVSCorvus Pharmaceuticals, Inc.Thompson Peter A.DirectorJun 10, 2016Buy$12.9820,000259,6005,319,966Jun 13, 2016, 05:23 PM
ADAPAdaptimmune Therapeutics PLCThompson Peter A.DirectorMay 20, 2016Buy$10.042,40024,09628,043,404May 25, 2016, 06:45 PM
ADAPAdaptimmune Therapeutics PLCThompson Peter A.DirectorMay 23, 2016Buy$10.401,191,60012,392,64029,235,004May 25, 2016, 06:45 PM
ADAPAdaptimmune Therapeutics PLCThompson Peter A.DirectorMay 24, 2016Buy$10.48518,4005,432,83229,753,404May 25, 2016, 06:45 PM
CRVSCorvus Pharmaceuticals, Inc.Thompson Peter A.DirectorMay 20, 2016Buy$13.094,71661,7325,269,966May 24, 2016, 04:48 PM
CRVSCorvus Pharmaceuticals, Inc.Thompson Peter A.DirectorMay 18, 2016Buy$11.554,20048,5105,262,650May 20, 2016, 04:27 PM
CRVSCorvus Pharmaceuticals, Inc.Thompson Peter A.DirectorMay 19, 2016Buy$12.132,60031,5255,265,250May 20, 2016, 04:27 PM
CRVSCorvus Pharmaceuticals, Inc.Thompson Peter A.DirectorMar 29, 2016Buy$15.00550,0008,250,0005,258,450Mar 29, 2016, 12:00 PM
DNAIProNAi Therapeutics IncThompson Peter A.DirectorJul 21, 2015Option Exercise$5.2289,159464,9641,814,949Jul 21, 2015, 07:03 PM
DNAIProNAi Therapeutics IncThompson Peter A.DirectorJul 21, 2015Buy$17.00175,0002,975,0001,989,949Jul 21, 2015, 07:03 PM